Anne Searls Degroot
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.2MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 22, 2019 | NIH | SBIR Phase I GAA-ITEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients | $134K | EPIVAX, INC. |
| Aug 27, 2018 | NIH | SBIR Phase I Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease | $140K | EPIVAX, INC. |
| May 9, 2018 | NIH | SBIR Phase I GAA-ITEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients | $191K | EPIVAX, INC. |
| Aug 24, 2017 | NIH | SBIR Phase I Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease | $177K | EPIVAX, INC. |
| Jun 21, 2017 | NIH | SBIR Phase I Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza | $291K | EPIVAX, INC. |
| Jun 27, 2016 | NIH | SBIR Phase I Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza | $300K | EPIVAX, INC. |
Peer ranks
Federal funding#1,576
Awards as PI#315
Patents#273
Companies
- EPIVAX, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.